Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List; Clarus (CRXT) and United Therapeutics (UTHR) Seeing Biggest Short Interest Increases Apr 12, 2022 05:53AM
Clarus (CRXT) PT Lowered to $3 at Cantor Fitzgerald Mar 31, 2022 06:23AM
VYNE Therapeutics (VYNE) and Ardelyx (ARDX) Top Cantor Fitzgerald's Most Shorted Biotech List Dec 28, 2021 05:55AM
Clarus Therapeutics Announces Closing of Approximately $15 Million Private Placement Dec 7, 2021 04:05PM
Clarus Therapeutics (CRXT) Announces 3.02M Share Private Placement at $4.96/sh Dec 3, 2021 09:05AM


Dec 3, 2021 09:05AM Clarus Therapeutics Announces $15 Million Private Placement
Sep 20, 2021 05:59AM UPDATE: Cantor Fitzgerald Starts Clarus (CRXT) at Overweight
Sep 9, 2021 12:46PM Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic Therapies